Cost Analyses of a Symptom-driven Inhaled Corticosteroid-Formoterol Treatment Strategy for Patients With Mild Asthma From a United States Payor Perspective

被引：0
|
作者：
Renaud, C. J. [1 ]
Jost, E. [2 ]
Barker, A. R. [2 ]
Montane, B. [3 ]
Simkovich, S. M. [4 ]
Sumino, K. [1 ]
Mcgregor, M. [1 ]
Castro, M. [5 ]
Bollmeier, S. [6 ]
Krings, J. G. [1 ]
机构：
[1] Washington Univ St Louis, Div Pulm & Crit Care Med, Sch Med, St Louis, MO USA
[2] Washington Univ St Louis, Brown Sch, St Louis, MO USA
[3] Washington Univ St Louis, Div Gen Med Sci, Sch Med, St Louis, MO USA
[4] Georgetown Univ, Div Pulm & Crit Care Med, Sch Med, Washington, DC USA
[5] Univ Kansas, Pulm Crit Care & Sleep Med, Kansas City, KS USA
[6] Univ Hlth Sci & Pharm, St Louis, MO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4489
引用
收藏
页数：2
相关论文
共 18 条
  • [1] A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma
    Krings, James G.
    Gerald, Joe K.
    Blake, Kathryn, V
    Krishnan, Jerry A.
    Reddel, Helen K.
    Bacharier, Leonard B.
    Dixon, Anne E.
    Sumino, Kaharu
    Gerald, Lynn B.
    Brownson, Ross C.
    Persell, Stephen D.
    Clemens, Conrad J.
    Hiller, Katherine M.
    Castro, Mario
    Martinez, Fernando D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (04) : 390 - 405
  • [2] Cost Analyses of an As-needed 60-actuation Vs. 120-actuation Budesonide-Formoterol pMDI for Patients With Mild Asthma From a United States Payor Perspective
    Stein, K. R.
    Jost, E.
    Barker, A. R.
    Wojcik, K. M.
    Chen, V.
    Bucha, S.
    Simkovich, S. M.
    Goss, C. W.
    Huffman, M. D.
    Agarwal, M.
    Sumino, K.
    Castro, M.
    Reddel, H. K.
    Pleasants, R.
    Krings, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [3] As-Needed Inhaled Corticosteroid-Formoterol in a Single Inhaler Compared to Inhaled Corticosteroid-Albuterol in Separate Inhalers as Reliever Therapy in Mild Pediatric Asthma: A Cost-Utility Analysis
    Rodriguez-Martinez, Carlos E.
    Sossa-Briceno, Monica P.
    Buendia, Jefferson Antonio
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
  • [4] Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial
    Baggott, Christina
    Reddel, Helen K.
    Hardy, Jo
    Sparks, Jenny
    Holliday, Mark
    Corin, Andrew
    Montgomery, Barney
    Reid, Jim
    Sheahan, Davitt
    Hancox, Robert J.
    Weatherall, Mark
    Beasley, Richard
    Fingleton, James
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (04)
  • [5] The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Golam, Sarowar
    Sadatsafavi, Mohsen
    RESPIRATORY MEDICINE, 2020, 171
  • [6] Patient Preferences for Symptom-Driven or Regular Preventer Treatment in Mild to Moderate Asthma: Findings From the PRACTICAL Study, a Randomised Clinical Trial
    Huddleston, Christina M.
    Kloepfer, Kirsten M.
    PEDIATRICS, 2020, 146 : S371 - S371
  • [7] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Sadatsafavi, Mohsen
    FitzGerald, J. Mark
    O'Byrne, Paul M.
    Soliman, Mena
    Sriskandarajah, Niroshan
    Vicente, Colin
    Golam, Sarowar Muhammad
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01):
  • [8] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Mohsen Sadatsafavi
    J. Mark FitzGerald
    Paul M. O’Byrne
    Mena Soliman
    Niroshan Sriskandarajah
    Colin Vicente
    Sarowar Muhammad Golam
    Allergy, Asthma & Clinical Immunology, 17
  • [9] Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial
    James G. Krings
    Kaitlyn M. Wojcik
    Vanessa Chen
    Tejas C. Sekhar
    Kelly Harris
    Abigail Zulich
    Kaharu Sumino
    Ross Brownson
    Eric Lenze
    Mario Castro
    Trials, 23
  • [10] Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial
    Krings, James G. G.
    Wojcik, Kaitlyn M. M.
    Chen, Vanessa
    Sekhar, Tejas C. C.
    Harris, Kelly
    Zulich, Abigail
    Sumino, Kaharu
    Brownson, Ross
    Lenze, Eric
    Castro, Mario
    TRIALS, 2022, 23 (01)
12